ClinicalTrials.govpublic full text
Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
acute myeloid leukemia, myeloid leukemia acute disease, tipifarnib, bone marrow aspirate, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895145
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.